Clinical Trials Sponsored by Roquette Canada, LTD.

Total 112 results

Roquette Canada, LTD.

Completed

Investigation of the Efficacy and Safety of Three Test Products and Comparator on Muscular Performance After the Initiation of a Resistance Training Program

Muscle Strength

Canada
Qanatpharma Canada LTD

Completed

Bioequivalence and Food Effect Bioavailability Study of Lumacaftor Film-Coated Tablets

Healthy Volunteer

Canada
Canadian Urology Research Consortium
Merck Frosst Canada Ltd.; Abbott

Terminated

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Osteoporosis
Piramal Healthcare Canada Ltd

Completed

Trial Comparing BST-CarGel and Microfracture in Repair of Articular Cartilage Lesions in the Knee

Knee Injuries

Korea, Republic of, Canada, Spain
Piramal Healthcare Canada Ltd

Completed

Follow-Up Study Evaluating The Long Term Safety and Efficacy of BST-CarGel and Microfracture Repair of the Knee

Knee Injuries

Spain, Canada
Canadian Heart Research Centre
Merck Frosst Canada Ltd.; Schering-Plough

Completed

Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE ) (GUIDE)

Cardiovascular Diseases

Canada
Virogin Biotech Canada Ltd

Recruiting

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Hepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma

United States
Virogin Biotech Canada Ltd

Recruiting

Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors

Solid Tumor

United States
Kamada, Ltd.

Completed

Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Israel
Kamada, Ltd.

Completed

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency (Kamada API)

Alpha 1-Antitrypsin Deficiency

United States
Kamada, Ltd.

Completed

Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation

Transplantation, Lung Rejection

Israel
Kamada, Ltd.

Completed

Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19

Pneumonia, Viral | Covid19

Israel
Kamada, Ltd.

Completed

Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation"

Alpha-1 Antitrypsin Deficiency

United States
Kamada, Ltd.

Completed

International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema

Emphysema

United Kingdom, Canada, Denmark, Germany, Ireland, Netherlands, Sweden
Kamada, Ltd.

Completed

Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects (KAMRAB-003)

Rabies

United States
Kamada, Ltd.

Completed

Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes

New Onset Type-1 Diabetes

Israel
Kamada, Ltd.

Completed

Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients

Cystic Fibrosis

Israel
University of British Columbia
Merck Frosst Canada Ltd.; Health Canada

Terminated

The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy

Hematuria | Hematospermia

Canada
NCIC Clinical Trials Group
Merck Frosst Canada Ltd.

Completed

MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Lung Cancer

Canada
Western University, Canada
TopSpin Technologies Ltd

Unknown

Cervicogenic Concussion Rehabilitation With TopSpin360

Concussion, Mild

Canada
Roquette Management (Shanghai) Co., Ltd.
Kaunas University of Medicine; West China College of Stomatology

Completed

Re-mineralization Effects of Sugar Free Chewing Gum Sweetened With Different Sugar-substitutes

Re-mineralization

China
Dalhousie University
Pfizer; Allergan; Merck Frosst Canada Ltd.; Glaucoma Research Society of Canada; Canadian...

Terminated

The Canadian Glaucoma Study

Glaucoma

Canada
Vancouver Island Health Authority
Canadian Society of Hospital Pharmacists; Jamieson Laboratories Ltd, Canada

Terminated

Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly

Diarrhea | Clostridium Difficile

Canada
John Papastergiou Pharmacy Ltd
Green Shield Canada

Completed

Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy

Depression | Mood Disorders | Generalized Anxiety Disorder | Anxiety | Major Depressive Disorder

Canada
Lundbeck Canada Inc.
Otsuka Pharmaceutical Co., Ltd.

Terminated

Real Life Assessment of Abilify Maintena (ReLiAM)

Schizophrenia

Canada
Organon and Co
Merck Frosst Canada Ltd.

Terminated

Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)

Atherosclerosis | Hypercholesterolemia
University of Alberta
Merck Frosst Canada Ltd.

Withdrawn

On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)

Benign Prostatic Hyperplasia

Canada
Kamada, Ltd.
Kedrion S.p.A.

Completed

Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies

Rabies

United States
Kamada, Ltd.
Syneos Health

Recruiting

Evaluate Efficacy and Safety of "Kamada-AAT for Inhalation" in Patients With AATD (InnovAATe)

Alpha 1-Antitrypsin Deficiency

United Kingdom, Sweden, Ireland, Netherlands, Belgium, Finland
University of Alberta
Merck Frosst Canada Ltd.; Heart and Stroke Foundation of Canada

Completed

Congestive Heart Failure Outreach Program (COPE)

Heart Failure

Canada
Sunnybrook Health Sciences Centre
Merck Frosst Canada Ltd.

Completed

Risk Factors Contributing to the Development of Microalbuminuria

Microalbuminuria

Canada
University Health Network, Toronto
Merck Frosst Canada Ltd.

Unknown

Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide

Glaucoma

Canada
LMC Diabetes & Endocrinology Ltd.
Novo Nordisk Canada Inc.

Completed

Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease

Chronic Kidney Diseases | Type 2 Diabetes

Canada
University Health Network, Toronto
Merck Frosst Canada Ltd.

Withdrawn

A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo

Pancreatic Adenocarcinoma | Metastatic Disease | Advanced Disease
University of British Columbia
Merck Frosst Canada Ltd.

Completed

Sitagliptin in the Elderly

Type 2 Diabetes

Canada
University Health Network, Toronto
Merck Frosst Canada Ltd.

Completed

A Trial of PROSCAR (Finasteride) Versus Placebo in Men With an Initial Negative Prostate Biopsy (Prostress)

Enlarged Prostate

Canada
St. Joseph's Healthcare Hamilton
Merck Frosst Canada Ltd.

Completed

Blown Nasal Secretion Measurements in Rhinosinusitis: Repeatability and Validity Compared to Nasal Lavage

Rhinosinusitis

Canada
Clinique du Quartier Latin
Merck Frosst Canada Ltd.

Unknown

HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance

HIV Infections

Canada, Martinique
Sunnybrook Health Sciences Centre
Merck Frosst Canada Ltd.

Terminated

Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot Study

Nausea | Vomiting

Canada
University Health Network, Toronto
Merck Frosst Canada Ltd.

Completed

Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans

Hyperlipidemia

Canada
Rabin Medical Center
Kamada, Ltd.

Completed

Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes (AAT Extension)

Type 1 Diabetes | Beta Cell Preservation

Israel
Canada Royal Enoch Phytomedicine Co., Ltd.
KGK Science Inc.

Recruiting

The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults

Fatigue | Cancer, Treatment-Related

Canada
The Hospital for Sick Children
Merck Frosst Canada Ltd.

Completed

Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma

Asthma, Bronchial

Canada
McMaster University
Merck Frosst Canada Ltd.; Public Health Agency of Canada (PHAC); Juravinski Cancer...

Unknown

Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV)

Cervical Intraepithelial Neoplasia | Human Papillomavirus Infection

Canada
Shanghai Kanda Biotechnology Co., Ltd.

Recruiting

KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma

Melanoma

China
Shanghai Kanda Biotechnology Co., Ltd.

Recruiting

A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

China
Shanghai Kanda Biotechnology Co., Ltd.

Not yet recruiting

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Other Solid Tumors | Advanced HCC

China
Shanghai Kanda Biotechnology Co., Ltd.

Completed

Clinical Study of KD6001 in Advanced Solid Tumours

Solid Tumor

China
LMC Diabetes & Endocrinology Ltd.
Public Health Agency of Canada (PHAC)

Active, not recruiting

The Canadian Diabetes Prevention Program (CDPP)

Diabetes type2

Canada
Sunnybrook Health Sciences Centre
Merck Frosst Canada Ltd.; Schering-Plough

Terminated

INdians Followed for INtensive Lipid Lowering Treatment and Its safetY (INFINITY)

Hypercholesterolemia

Canada

Clinical Trials Sponsored by Roquette Canada, LTD.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations